Get notified when SMMT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: SMMT Summit Therapeutics Inc. 8-K

Summit execs signal likely near-term share purchases; board approves affiliate ATM buys

Filed June 3, 2026 · Period ending June 2, 2026 · ~1 min read

Key Changes

  • high

    Co-CEOs Duggan and Zanganeh, plus CFO Soni, indicated they are likely to personally buy shares through the company's at-the-market offering in the near term at market prices, though no binding commitments or amounts were specified.

  • medium

    Board's Audit Committee and independent directors authorized company affiliates to purchase shares through the existing ATM program with JP Morgan, potentially providing capital while signaling confidence.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade SMMT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify